Table 1: Summary of Identified Active Compounds and Corresponding Targets

Synergistic Effects of Herbal Compounds on Lipid Metabolism in Liver Cancer

The interplay between lipid metabolism and liver cancer progression has been well-documented. Dysregulation of lipid homeostasis is a hallmark of NAFLD, a significant risk factor for liver cancer. Herbal compounds found in CRP and RJ play crucial roles in modulating lipid metabolism, thereby influencing hepatocellular health and cancer risk.

Research indicates that CRP can enhance lipid metabolism by regulating key enzymes involved in fatty acid oxidation and cholesterol biosynthesis. For example, flavonoids such as hesperidin and naringin have shown the ability to reduce lipid accumulation in hepatocytes, thereby preventing the progression of NAFLD and subsequent liver cancer development (Wang et al., 2023) [11].

Similarly, RJ compounds such as resveratrol and polydatin have demonstrated the capacity to ameliorate lipid dysregulation and reduce inflammation in liver tissues, further supporting their role in the prevention of liver cancer. The combined effects of these herbal compounds suggest that they can serve as effective adjuncts in liver cancer therapy by targeting lipid metabolism, reducing inflammation, and enhancing overall liver function.

Table 2: Summary of Mechanisms Affecting Lipid Metabolism

Conclusion

The integration of Citri Reticulatae Pericarpium and Reynoutria japonica into liver cancer treatment represents a promising avenue for enhancing therapeutic efficacy through multi-targeted mechanisms. By leveraging the pharmacological properties of these herbal compounds, clinicians may be able to improve patient outcomes and reduce the burden of liver cancer.

Research utilizing network pharmacology has elucidated the complex interactions between these compounds and their molecular targets, highlighting the potential for CRP and RJ to address not only liver cancer but also the underlying metabolic disorders associated with its progression. Continued exploration of these herbal remedies through rigorous clinical trials and in-depth mechanistic studies will pave the way for novel therapeutic strategies in the fight against liver cancer.

FAQ

What is liver cancer?

Liver cancer is a type of cancer that originates in the liver cells, with hepatocellular carcinoma being the most common subtype. It often develops in the context of chronic liver diseases such as hepatitis or cirrhosis.

How do Citri Reticulatae Pericarpium and Reynoutria japonica work against liver cancer?

These herbs contain bioactive compounds that inhibit cancer cell proliferation, induce apoptosis, and modulate inflammatory responses, thereby targeting multiple pathways involved in liver cancer progression.

What are the benefits of using herbal remedies in cancer treatment?

Herbal remedies like CRP and RJ can provide multi-targeted therapeutic effects with fewer side effects compared to conventional treatments, enhancing overall patient outcomes.

Are there any side effects associated with these herbal treatments?

While generally considered safe, the potential for side effects exists, particularly related to specific compounds. Comprehensive evaluations of their toxicity profiles are necessary.

How can network pharmacology aid in drug development?

Network pharmacology helps identify the complex interactions between drugs, targets, and pathways, providing insights into multi-target therapies and facilitating the development of more effective treatment strategies.

References

1. Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., et al. (2019). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 69(6), 504-547

2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3), 209-249

3. Anwanwan, D., Singh, S. K., Singh, S., Saikam, V., & Singh, R. (2020). Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer, 1861(3), 188314. https://doi.org/10.1016/j.bbcan.2019.188314

4. Naz, H., Tarique, M., Ahamad, S., Alajmi, M. F., Hussain, A., et al. (2019). Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells. J Cell Biochem, 120(4), 5754-5764

5. Li, P., Wang, J., Zhao, M., Zhang, D., Wang, Y., et al. (2015). Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway. Expert Opin Ther Targets, 19(10), 1301-1315. https://doi.org/10.1517/14728222.2015.1054806

6. Gao, S., Chen, X., Yu, Z., Du, R., Chen, B., et al. (2023). Progress of research on the role of active ingredients of Citri Reticulatae Pericarpium in liver injury. Phytomedicine, 107, 154836. https://doi.org/10.1016/j.phymed.2023.154836

7. Zhou, Y., Que, R. Y., Li, Y., Zhu, L. (2023). The effects of resveratrol on NLRP3 inflammasome expression in a mouse model of acute liver injury. World Clin Drugs, 2020

8. Wang, J., Zhang, J., Guo, Z., Hua, H., Zhang, H., et al. (2024). Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives. Phytomedicine, 2024. https://doi.org/10.1016/j.phymed.2023.155156

9. Lin, C., Wang, Y., & Xie, H. (2025). To reveal the key mechanism of Citri Reticulatae Pericarpium–Reynoutria japonica Houtt in the treatment of liver cancer and its correlation with lipid metabolism: synergetic effect with network pharmacology, molecular docking, and bioinformatics. Discover Oncology, 2025. https://doi.org/10.1007/s12672-025-02708-8

10. Zhang, P., Jiang, Y., Zeng, J., Li, X., Xie, H., et al. (2023). Mechanism of Citri Reticulatae Pericarpium as an anticancer agent from the perspective of flavonoids: A review. Molecules, 27(15), 5622

11. Wang, J., Zhang, X., Yang, W., Jiang, M. (2023). Involvement of bile acid metabolism and gut microbiota in the amelioration of experimental metabolism-associated fatty liver disease by nobiletin. Molecules, 29(5), 976